Source: Annual Congress 2001 - Disease of the pulmonary circulation



Rating:

Share or cite this content

Citations should be made in the following way:
A. A. Demin, V. P. Drobysheva, O. Y. Welter (Novosibirsk, Russia). Pulmonary complications of infective endocarditis in intravenous drug users. Eur Respir J 2001; 16: Suppl. 31, 3511

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary onset and complications of intravenous drug users infective endocarditis Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018 Lung injury in intravenous drug users with infective endocarditis Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Pulmonary hypertension in patients with infective endocarditis Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Septic pulmonary embolism in intravenous drug users. Source: International Congress 2017 – Pulmonary embolism Year: 2017 Pulmonary pathology in fatal intravenous heroin addicts Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003 Pleuropulmonary manifestations of infective endocarditis Source: Eur Respir J 2003; 22: Suppl. 45, 47s Year: 2003 Uncommon pulmonary complications of inhaled cannabinoide Source: Eur Respir J 2004; 24: Suppl. 48, 537s Year: 2004 Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006 Safety of intravenous amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Severe respiratory illness in an intravenous drug abuser Source: ISSN=ISSN 1810-6838, ISBN=, page=207 Year: 2006 Pulmonary complications in severe malaria Source: Eur Respir J 2003; 22: Suppl. 45, 451s Year: 2003 The use of perioperative intravenous sildenafil in patients with mitral valve disease and co-existent pulmonary hypertension during cardiac surgery Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Pulmonary infections in neutropenic patients Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Pulmonary complications of HIV infection Source: Annual Congress 2007 - ACCP 2 - Pulmonary complications of HIV infection Year: 2007 Broviac catheter complications of intravenous epoprostenol therapy in patients with pulmonary arterial hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 636s Year: 2004 Complications of anticoagulant therapy in patients with pulmonary thromboembolism Source: Eur Respir J 2007; 30: Suppl. 51, 604s Year: 2007 High incidence of bacteraemia complicating iv prostaglandin therapy in patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 371s Year: 2002 Systemic corticosteroid for treating severe community-acquired pneumonia Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014